IBO
Price
$5.32
Change
-$0.11 (-2.03%)
Updated
Oct 2, 02:26 PM (EDT)
Capitalization
47.93M
Intraday BUY SELL Signals
INDP
Price
$2.38
Change
+$0.26 (+12.26%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
438.37M
Intraday BUY SELL Signals
Interact to see
Advertisement

IBO vs INDP

IBO vs INDP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IBO vs. INDP commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBO is a StrongBuy and INDP is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IBO vs INDP: Fundamental Ratings
IBO
INDP
OUTLOOK RATING
1..100
9794
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8100
PRICE GROWTH RATING
1..100
7335
P/E GROWTH RATING
1..100
36100
SEASONALITY SCORE
1..100
3090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBO's Valuation (73) in the null industry is in the same range as INDP (76). This means that IBO’s stock grew similarly to INDP’s over the last 12 months.

IBO's Profit vs Risk Rating (100) in the null industry is in the same range as INDP (100). This means that IBO’s stock grew similarly to INDP’s over the last 12 months.

IBO's SMR Rating (8) in the null industry is significantly better than the same rating for INDP (100). This means that IBO’s stock grew significantly faster than INDP’s over the last 12 months.

INDP's Price Growth Rating (35) in the null industry is somewhat better than the same rating for IBO (73). This means that INDP’s stock grew somewhat faster than IBO’s over the last 12 months.

IBO's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for INDP (100). This means that IBO’s stock grew somewhat faster than INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IBOINDP
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (IBO: $5.43 vs. INDP: $2.12)
Brand notoriety: IBO and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBO: 65% vs. INDP: 31%
Market capitalization -- IBO: $47.93M vs. INDP: $438.37M
IBO [@Biotechnology] is valued at $47.93M. INDP’s [@Biotechnology] market capitalization is $438.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBO’s FA Score shows that 1 FA rating(s) are green while INDP’s FA Score has 0 green FA rating(s).

  • IBO’s FA Score: 1 green, 4 red.
  • INDP’s FA Score: 0 green, 5 red.
According to our system of comparison, IBO is a better buy in the long-term than INDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBO’s TA Score shows that 4 TA indicator(s) are bullish while INDP’s TA Score has 6 bullish TA indicator(s).

  • IBO’s TA Score: 4 bullish, 6 bearish.
  • INDP’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, INDP is a better buy in the short-term than IBO.

Price Growth

IBO (@Biotechnology) experienced а -3.89% price change this week, while INDP (@Biotechnology) price change was -47.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IBO
Daily Signal:
Gain/Loss:
INDP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SERV4.750.10
+2.15%
Serve Robotics
EGHAU10.66N/A
N/A
EGH Acquisition Corp.
VSAT70.35-0.03
-0.04%
ViaSat
MYPS4.72-0.03
-0.61%
PLAYSTUDIOS
DHC7.74-0.11
-1.40%
Diversified Healthcare Trust

IBO and

Correlation & Price change

A.I.dvisor tells us that IBO and PCSA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IBO and PCSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBO
1D Price
Change %
IBO100%
-3.04%
PCSA - IBO
32%
Poorly correlated
-1.22%
INDP - IBO
27%
Poorly correlated
-7.83%
LPCN - IBO
27%
Poorly correlated
-5.91%
AZTR - IBO
26%
Poorly correlated
-6.61%
LIMN - IBO
24%
Poorly correlated
+1.61%
More

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with VERU. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-7.83%
VERU - INDP
47%
Loosely correlated
-4.51%
ALT - INDP
45%
Loosely correlated
-3.50%
NBP - INDP
38%
Loosely correlated
-1.83%
VKTX - INDP
30%
Poorly correlated
-6.41%
ORMP - INDP
29%
Poorly correlated
-4.07%
More